Skip to main content
Log in

Regional hospitalisation and seasonal variations of Pediatric rotavirus gastroenteritis pre- and post-RV vaccination: a prospective and retrospective study

  • Original Article
  • Published:
World Journal of Pediatrics Aims and scope Submit manuscript

Abstract

Background

Rotavirus is the primary cause of gastroenteritis in children worldwide and is a leading cause of gastroenteritis in children, with a significant burden. Rotavirus vaccine became available in Ireland in 2016. This study aimed to investigate hospital admissions and seasonal characteristics of rotavirus gastroenteritis in a pre- and post-vaccination period in a single district general hospital.

Methods

In the post-vaccination year, from November 18th 2016 to November 18th 2017, all children up to 3 years of age who presented to Mayo University Hospital with vomiting and diarrhea, were recruited and had their stool tested for rotavirus. Retrospective analysis of hospital data of children of the same age during pre-vaccination years (2014–2016) were used for comparison.

Results

Compared with the pre-vaccination years (2014–2016), the median percentages of reduction of rotavirus positive stool requests and hospital admissions were high, 48.5% and 73%, respectively. In the post-vaccination year, the median percentage of reduction of emergency department presentation (stool requests) with gastroenteritis was 9%. No delay in the onset of RV season or reduction of the peak of RV infection was noted in the post-vaccination year. The duration of rotavirus season in 2016/2017 was short.

Conclusions

Compared with 3 pre-vaccination years, the total number of gastroenteritis presentations, gastroenteritis hospital admissions, and rotavirus positive gastroenteritis cases were all reduced, and the duration of the rotavirus season was shorter.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Data availability statement

Available upon reasonable request.

References

  1. Karafillakis E, Hassounah S, Atchison C. Effectiveness and impact of rotavirus vaccines in Europe, 2006–2014. Vaccine. 2015;33:2097–107.

    Article  Google Scholar 

  2. Weidemann F, Dehnert M, Koch J, Wichmann O, Höhle M. Modelling the epidemiological impact of rotavirus vaccination in Germany–a Bayesian approach. Vaccine. 2014;32:5250–7.

    Article  Google Scholar 

  3. Uhlig U, Kostev K, Schuster V, Koletzko S, Uhlig HH. Impact of rotavirus vaccination in Germany: rotavirus surveillance, hospitalization, side effects and comparison of vaccines. Pediatr Infect Dis J. 2014;11:299–304.

    Article  Google Scholar 

  4. Vesikari T, Uhari M, Renko M, Hemming M, Salminen M, Torcel-Pagnon L, et al. Impact and effectiveness of RotaTeq® vaccine based on 3 years of surveillance following introduction of a rotavirus immunization program in Finland. Pediatr Infect Dis J. 2013;12:1365–73.

    Article  Google Scholar 

  5. Martinón-Torres F, Aramburo A, Martinón-Torres N, Cebey M, Seoane-Pillado MT, Redondo-Collazo L, et al. A reverse evidence of rotavirus vaccines impact. Hum Vaccine Immunother. 2013;9:1289–91.

    Article  Google Scholar 

  6. Koch J, Wiese-Posselt M, Remschmidt C, Wichmann O, Bertelsmann H, Garbe E, et al. Background paper to the recommendation for routine rotavirus vaccination of infants in Germany. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2013;56:957–84.

    Article  CAS  Google Scholar 

  7. Tilson L, Jit M, Schmitz S, Walsh C, Garvey P, McKeown P, et al. Cost-effectiveness of universal rotavirus vaccination in reducing rotavirus gastroenteritis in Ireland. Vaccine. 2011;29:7463–73.

    Article  CAS  Google Scholar 

  8. Macartney KK, Power M, Dalton D, Cripps T, Maldigri T, Isaacs D, et al. Decline in rotavirus hospitalisations following introduction of Australia’s national rotavirus immunisation programme. J Paediatr Child Health. 2011;47:266.

    Article  Google Scholar 

  9. O’Ryan M, Lucero Y, Linhares AC. Rotarix®. Vaccine performance 6 years post licensure. Expert Rev Vaccines. 2011;12:1645–59.

    Article  Google Scholar 

  10. Tiemessen CT, Nel MJ. Detection and typing of subgroup F adenoviruses using the polymerase chain reaction. J Virol Methods. 1996;59:73–82.

    Article  CAS  Google Scholar 

  11. Paulke-Kronek M, Rendi-Wagner P, Kundi M, Kronik R, Kollaritsch H. Universal mass vaccination against rotavirus gastroenteritis: impact on hospetalisationrates in Austrian children. Pediatr Infect Dis J. 2010;29:319–23.

    Article  Google Scholar 

  12. Buttery JP, Lamber SB, Grimwood K, Nissen MD, Field EJ, Macartney KK, et al. Reduction in Rotavirus- associated gastroenteritis following introdiction of rotavirus vaccine into Australia’s national childhood vaccine schedule. Pediatr Infect Dis J. 2011;30:S25–S29.

    Article  Google Scholar 

  13. Giaquinto C, Dominiak-Felden G, Van Damme P, Myint TT, Maldonado YA, Spoulou V, et al. Summary of effectiveness and impact of rotavirus vaccination with the oral pentavalent rotavirus vaccine: a systematic review of the experience in industrialized countries. Hum Vaccin. 2011;7:734–48.

    Article  Google Scholar 

  14. Gray J. Rotavirus vaccines: safety, efficacy and public health impact. J Intern Med. 2011;270:206–14.

    Article  CAS  Google Scholar 

  15. Braeckman T, Van Herck K, Raes M, Vergison A, Sabbe M, Van Damme P. Rotavirus vaccines in Belgium: policy and impact. Pediatr Infect Dis J. 2011;30:S21–4.

    Article  Google Scholar 

  16. Chhabra P, Payne DC, Szilagyi PG, Edwards KM, Staat MA, Shirley SH, et al. Etiology of viral gastroenteritis in children <5 years of age in the United States, 2008–2009. J Infect Dis. 2013;208:790.

    Article  Google Scholar 

  17. Osborne CM, Montano AC, Robinson CC, Robinson CC, Schultz-Cherry S, Dominguez SR. Viral gastroenteritis in children in Colorado 2006–2009. J Med Virol. 2015;87:931.

    Article  CAS  Google Scholar 

  18. Hall AJ, Rosenthal M, Gregoricus N, Greene SA, Ferguson J, Henao OL, et al. Incidence of acute gastroenteritis and role of norovirus, Georgia, USA, 2004–2005. Emerg Infect Dis. 2011;17:1381.

    Article  Google Scholar 

  19. Zimmerman CM, Bresee JS, Parashar UD, Riggs TL, Holman RC, Glass RI. Cost of diarrhea-associated hospitalizations and outpatient visits in an insured population of young children in the United States. Pediatr Infect Dis J. 2001;20:14.

    Article  CAS  Google Scholar 

  20. Dennehy PH. Viral gastroenteritis in children. Pediatr Infect Dis J. 2011;30:63.

    Article  Google Scholar 

  21. Lee RM, Lessler J, Lee RA, Rudolph KE, Reich NG, Perl TM, et al. Incubation periods of viral gastroenteritis: A systematic review. BMC Infect Dis. 2013;13:446.

    Article  Google Scholar 

  22. Public Health Agency of Canada. Adenovirus (serotypes 40 & 41). Pathogen safety data sheet-infectious substances 2010. Accessed 10 Sept 2019

  23. Koh H, Beak SY, Shin JY, Chung KS, Jee YM. Coinfection of viral agents in Korean children with acute watery diarrhoea. J Korean Med Sci. 2008;23:937–40.

    Article  Google Scholar 

  24. Macartney KK, Power M, Dalton D, Cripps T, Maldigri T, Isaacs D, et al. Decline in Rotavirus hospitalisations following introduction of Australia’s national rotavirus immunisation programme. J Paediatr Child Health. 2011;47:266–70.

    Article  Google Scholar 

  25. Miren Iturriza-Gomara, Daniel Humgerford. European rotavirus surveillance network. Annual report 2017. Accessed 10 Sept 2019

  26. Hungerford D, Vivancos R, Read JM, Iturriza-Gomara M, French N, Cunliffe NA. Rotavirus vaccine impact and socioeconomic deprivation: an interrupted time-series analysis of gastrointestinal disease outcomes across primary and secondary care in the UK. BMC Med. 2018;16:10.

    Article  Google Scholar 

  27. Zellar M, Rahman M, Heylen E, De Coster S, De Vos S, Arijs I, et al. Rotavirus incidence and genotype distribution before and after national rotavirus vaccine introduction in Belgium. Vaccine. 2010;28:7507–1.

    Article  Google Scholar 

Download references

Acknowledgements

I greatly thank Ms Zoe Yandle (Clinical Scientist at the National Virus Reference Laboratory-Dublin) for her kind assistance in relation to performing laboratory investigations and was happy with submission for publication.

Funding

None.

Author information

Authors and Affiliations

Authors

Contributions

ZB was responsible for conceptualization, study design, study protocol, data collection and management, literature search, writing original draft, review & editing, and submitting the final version of the manuscript.

Corresponding author

Correspondence to Zakaria Barsoum.

Ethics declarations

Conflict of interest

No financial or non- financial benefits have been received or will be received from any part related directly or indirectly to the subject of this article.

Ethics approval

Obtained from Ethical Committee at Mayo University Hospital prior to study commencement (Ref TOM/DP).

Consent to participate

Obtained from carers of children.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 16 KB)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Barsoum, Z. Regional hospitalisation and seasonal variations of Pediatric rotavirus gastroenteritis pre- and post-RV vaccination: a prospective and retrospective study. World J Pediatr 18, 404–416 (2022). https://doi.org/10.1007/s12519-022-00546-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12519-022-00546-0

Keywords

Navigation